PROtein S100B for Mild Trauma of the HEad in Emergency Patients
NCT03313505 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 787
Last updated 2021-07-29
Summary
Brain injury is a frequent purpose for consultation in emergency services. Management of brain injury is time and resource consuming, combining clinical monitoring and imaging.
The stage prior to the management of the victims of brain injury is stratification of the severity, potential or proven.
Severe brain injury requires emergent brain CT-scan, ideally within one hour of the first medical contact. Patients requiring this strategy present with focused neurological deficit, Glasgow score \<15 to 2 hours after the trauma, suspicion of open fracture of the skull or dish pan fracture, any signs of fracture of the skull base (hemotympanum, bilateral peri-orbital ecchymosis), otorrhea or rhinorrhea of cerebrospinal fluid, more than one episode of vomiting in adults, and posttraumatic convulsion. Patients benefiting from anticoagulant therapy are included in this category.
Victims of brain injury that do not fall into this category are considered less critical.
By definition, mild traumatic brain injury :
* a trauma of the cephalic extremity :
* whose Glasgow score (30 min after the trauma or during the consultation) is 13-15,
* associated with one or more of the following: confusion; disorientation; loss of consciousness of 30 min or less; post-traumatic amnesia of less than 24 hours; other transient neurological abnormalities (focal signs, epileptic seizures, non-surgical intracranial lesion).
Among these patients, some are considered at risk of developing intracerebral lesions. Nevertheless, it should be noted that the prevalence of hemorrhagic complications is radically different between patients with a Glasgow score of 13 and those with a score of 15. Thus, the recommendations suggest a brain scan without injection of contrast media within 4 to 8 hours for patients with the following characteristics :
* a retrograde amnesia of more than 30 minutes,
* a loss of consciousness or amnesia associated with:
* either a risk mechanism (pedestrian overturned by a motor vehicle, ejection of a vehicle, falling by more than one meter),
* or an age\> 65 years,
* or coagulation disorders, including the use of platelet aggregation therapy. Patients who fall outside this definition are considered low risk of complication and should not benefit of imaging.
Data from the scientific literature show that an early brain CT-scan allows identification of post-traumatic lesions in this population. Nevertheless, organizational problems, including the availability of the imaging, radiation, and disruption of surveillance related to patient displacement, are limitations to this strategy. In contrast, the low cost-effectiveness of CT scan is often advocated in patients with mild traumatic brain injury. For example, in the Octopus study, 52 of 1316 patients who received CT scan after mild head trauma had an intracerebral lesion. Among these patients, 39 (3%) had intracerebral lesion related to trauma; for 13 (1%) patients, the link with the trauma was uncertain.
In fact, the search of alternatives for a safer, more conservative, more efficient practice, one of the objectives of which is to limit the undue use of cerebral scanning. Thus, many teams have been interested in the use of biological variables to guide the decision to use imagery.
Among candidate biomarkers, the S100B protein has been the subject of many evaluations which allow it to be used in current practice. Indeed, the increase of the S100B protein carried out within 3 hours following a mild head trauma makes it possible to identify the patients at risk of intracerebral lesion and to target the indications of imaging.
The purpose of the registry is to describe the use, interpretation and performance of the S100B protein in its use at bedside in emergency medicine.
Conditions
- Mild Traumatic Brain Injury
Interventions
- BIOLOGICAL
-
S100B protein dosage
S100B protein dosage will be carried out, by a blood sample, on the earliest after admission and before 3th hour following brain injury S100B protein dosage will be left to the assessment of the emergency physician in charge of the patient
- OTHER
-
Brain CT scan
No injected brain CT-scan, regardless of the time between the brain injury and the arrival in the emergency unit. Realization of CT-scan will be left to the assessment of the emergency physician in charge of the patient
Sponsors & Collaborators
-
Centre Hospitalier Princesse Grace
lead OTHER
Principal Investigators
-
Yann-Erick CLAESSENS, PU-PH · Centre Hospitalier Princesse Grace
-
Karim TAZAROURTE, PU-PH · Hospices Civils de Lyon
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-05-14
- Primary Completion
- 2021-07-15
- Completion
- 2021-07-22
Countries
- France
- Monaco
Study Locations
More Related Trials
-
Mannitol vs HS to Treat ICHT After Severe TBI : Comparison on PtiO2 and Microdialysis Values
NCT01028339 ·Status: TERMINATED ·Phase: PHASE3
-
Efficacy of Early Continuous Infusion of HSS on the Neurological Outcome at 6 Months in TBI Patients.
NCT07319208 ·Status: RECRUITING ·Phase: PHASE3
-
Point of Care Testing in Emergency Departments After Mild Traumatic Brain Injury
NCT07129577 ·Status: NOT_YET_RECRUITING
-
Effect of Progesterone Administration on Severely Head Injured Patients
NCT06631547 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
Beta Blockade in in Traumatic Brain Injury
NCT02957331 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of 2 Doses of Mannitol on Post Traumatic Intracranial Hypertension and Cerebral Monitoring
NCT00795587 ·Status: TERMINATED ·Phase: PHASE4
-
Use of Cerebral Biomarkers in Minor Traumatic Brain Injury in the Emergency Unit
NCT06069674 ·Status: RECRUITING
-
Early Propranolol After Traumatic Brain Injury: Phase II
NCT01202110 ·Status: TERMINATED ·Phase: PHASE2
-
Progesterone for the Treatment of Traumatic Brain Injury III
NCT00822900 ·Status: TERMINATED ·Phase: PHASE3
-
Study of Cerebral Tissue Oxygenation During Transfusion in Traumatic Brain Injury
NCT01728831 ·Status: COMPLETED
-
Impact of Cardiac Blood Flow on Cerebral Blood Flow in Patients With Severe Traumatic Brain Injury
NCT02019810 ·Status: UNKNOWN ·Phase: PHASE2
-
Predict Severe Traumatic Brain Injury
NCT06966713 ·Status: RECRUITING
-
Ghrelin (OXE--103) for Acute Concussion Management
NCT04558346 ·Status: COMPLETED ·Phase: PHASE2
-
Platelet Inhibitor Treated Patients With Head Injury Trauma Meeting NICE Criteria : is the CT-scan Mandatory ?
NCT03687528 ·Status: RECRUITING
-
Role of Non-Selective Beta-Adrenergic Blocker in Severe TBI
NCT06870370 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Propranolol for the Treatment of Traumatic Brain Injury
NCT06262061 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1
-
Pre-hospital and Intra-hospital Temporal Delays in Patients Requiring Emergent Trauma Craniotomy
NCT02803112 ·Status: TERMINATED
-
Sevoflurane Sedation on Intra Cranial Pressure in Traumatic Brain Injury Patients
NCT01374633 ·Status: TERMINATED ·Phase: PHASE2
-
mTBI Mechanisms of Action of HBO2 for Persistent Post-Concussive Symptoms
NCT01611194 ·Status: COMPLETED ·Phase: PHASE2
-
Multimodal Neuromonitoring in Acute Brain Injury
NCT06302244 ·Status: COMPLETED
-
BLOOD BIOMARKERS in PAEDIATRIC MTBI
NCT06233851 ·Status: COMPLETED
-
Hypertonic Resuscitation Following Severe Traumatic Brain Injury (TBI)
NCT00316004 ·Status: TERMINATED ·Phase: PHASE3
-
High Dose Hyperoncotic Serum Albumin for the Treatment of the Acute Phase of Severe Head Injury
NCT00152685 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Effects of Erythropoietin on Cerebral Vascular Dysfunction and Anemia in Traumatic Brain Injury
NCT00313716 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Cerebral Autoregulation, Brain Perfusion, and Neurocognitive Outcomes After Traumatic Brain Injury
NCT06480838 ·Status: RECRUITING